Replies to post #337953 on Amarin Corp Plc (AMRN)

[hamkypamky]

Agree.

My fairly optimistic read of the situation is that we can probably maintain between $500-$1B annual sales in Vascepa over the next 5 years.

Not a lot for sure and a far cry from projections post approval

But still roughly $1B in free cash flow assuming EU operations cover HQ overheads (roughly 20% net margins after us sg&a)

[mrmainstreet]

This would be a lot easier to stomach if we saw the entire market growing and scripts launching past 100k. But for some reason even though the generics have a supply problem we are stuck in the mud too.

The covid excuse is not going to last forever.